Scientific PaperTall cell papillary thyroid cancer: Incidence and prognosis*
References (15)
- et al.
Prognostic factors in differential carcinoma of the thyroid gland
Am J Surg.
(1992) - et al.
Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue
Hum Pathol.
(1992) Nomenclature of thyroid tumors
- et al.
Thyroid cancer: a lethal endocrine neoplasm
Ann Int Med.
(1991) - et al.
Prognostic implications of the tall cell variant of papillary thyroid carcinomas
Am J Surg Pathol.
(1988) - et al.
The many appearances of papillary carcinoma of the thyroid
Cleve Clin Q.
(1976) - et al.
Papillary carcinoma of the thyroid oxyphil-cell type, clear cell variant
Am J Surg Pathol.
(1980)
Cited by (75)
Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis
2022, Pathology Research and PracticeThe evolving concept of aggressive histological variants of differentiated thyroid cancer
2020, Seminars in Diagnostic PathologyCitation Excerpt :Consequently, it is evident that a patient's PTC may or may not be diagnosed as TCV depending on the aforementioned factors. Despite all these conundrums, many studies with various designs and statistical analyses, including meta-analyses and large cancer registry studies, have reinforced the apparent more aggressive clinical behavior for TCV, when compared to classic PTC.18–22,25–28,32–34 Conclusions derived from these studies have reported that TCV is associated with older age at diagnosis, higher rate of gross extrathyroidal extension, increased lymph node and distant metastasis, and reduced disease-specific survival.18–22,25–28,32–34
Operative management of locally advanced, differentiated thyroid cancer
2016, Surgery (United States)Citation Excerpt :The vast majority of patients (98%) in our series presented with papillary carcinoma, and in later years, tall cell variant of papillary carcinoma was noted in up to 38% of cases. This is a far greater rate than the reported general incidence of tall cell carcinoma within standard groups of DTC patients27 and is congruent with its recognized association with ETE and increasing age.28 In terms of factors prognostic of oncologic outcome in this group of patients, Rosa Pelizzo et al18 found that older age, more extensive disease, less than total thyroidectomy, and no neck dissection were all independently predictive of poor outcome.
A nomogram and risk classification system for predicting cancer-specific survival in tall cell variant of papillary thyroid cancer: a SEER-based study
2023, Journal of Endocrinological InvestigationRisk Factors Associated with Recurrence and Death in Patients with Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study with Predictive Nomogram
2023, JAMA Otolaryngology - Head and Neck Surgery
- *
Presented at the joint meeting of the Society of Head and Neck Surgeons and the European Organization for Research and Treatment of Cancer (EORTC), Paris, France, May 25–28, 1994.